SCHEMBL30888664

SCHEMBL30888664

COc1c(Cl)cc2c(c1Br)C(=O)CCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB4A P04350 2/20 0.38
▸ TUBB P07437 2/20 0.38
▸ TUBA3C P0DPH7 2/20 0.38
▸ TUBA1B P68363 2/20 0.38
▸ TUBA4A P68366 2/20 0.38
▸ TUBB4B P68371 2/20 0.38
▸ TUBB3 Q13509 2/20 0.38
▸ TUBB2A Q13885 2/20 0.38
▸ TUBB8 Q3ZCM7 2/20 0.38
▸ TUBA3E Q6PEY2 2/20 0.38
▸ TUBA1A Q71U36 2/20 0.38
▸ TUBA1C Q9BQE3 2/20 0.38
▸ TUBB6 Q9BUF5 2/20 0.38
▸ TUBB2B Q9BVA1 2/20 0.38
▸ TUBB1 Q9H4B7 2/20 0.38
▸ BRD4 O60885 1/20 0.36
▸ PTGS2 P35354 2/20 0.35
▸ HSD17B1 P14061 1/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30888674 0.78 DRD2 (0.40) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7950375 0.73 TUBB4A (0.40) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL24755482 0.73 EGFR (0.41) BRD4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL30049403 0.73 EGFR (0.41) BRD4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL30550465 0.71 EGFR (0.42) BRD4ALDH1A1MEN1GAAKMT2A
SCHEMBL25307258 0.71 EGFR (0.42) BRD4ALDH1A1MEN1GAAKMT2A
SCHEMBL26916261 0.70 MAOA (0.37) BRD4ALDH1A1MAPTNPSR1LMNA
SCHEMBL10629307 0.70 TUBB4A (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL15898570 0.70 ALDH1A1 (0.42) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL31040035 0.70 KDM4E (0.49) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630403-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 — — EP disclosed
WO-2024121129-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 — — WO disclosed
Send feedback